241 related articles for article (PubMed ID: 14502565)
41. Inhibition of Friend erythroleukemic cell differentiation by bromodeoxyuridine: correlation with the amount of bromodeoxyuridine in DNA.
Ashman CR; Davidson RL
J Cell Physiol; 1980 Jan; 102(1):45-50. PubMed ID: 6445371
[TBL] [Abstract][Full Text] [Related]
42. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
Potter AJ; Rabinovitch PS
Mutat Res; 2005 May; 572(1-2):27-44. PubMed ID: 15790488
[TBL] [Abstract][Full Text] [Related]
43. Hematopoietic stem cell aging is associated with functional decline and delayed cell cycle progression.
Noda S; Ichikawa H; Miyoshi H
Biochem Biophys Res Commun; 2009 May; 383(2):210-5. PubMed ID: 19345668
[TBL] [Abstract][Full Text] [Related]
44. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
45. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
[TBL] [Abstract][Full Text] [Related]
46. Time-dependent segmentation of BrdU-signal leads to late detection problems in studies using BrdU as cell label or proliferation marker.
Sauerzweig S; Baldauf K; Braun H; Reymann KG
J Neurosci Methods; 2009 Feb; 177(1):149-59. PubMed ID: 19007815
[TBL] [Abstract][Full Text] [Related]
47. Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo.
Terry NH; White RA
Nat Protoc; 2006; 1(2):859-69. PubMed ID: 17406318
[TBL] [Abstract][Full Text] [Related]
48. The evaluation of early embryonic neurogenesis after exposure to the genotoxic agent 5-bromo-2'-deoxyuridine in mice.
Kuwagata M; Ogawa T; Nagata T; Shioda S
Neurotoxicology; 2007 Jul; 28(4):780-9. PubMed ID: 16956662
[TBL] [Abstract][Full Text] [Related]
49. Flow cytometry-based cell cycle measurement of mouse hematopoietic stem and progenitor cells.
Shen H; Boyer M; Cheng T
Methods Mol Biol; 2008; 430():77-86. PubMed ID: 18370292
[TBL] [Abstract][Full Text] [Related]
50. Low doses of bromo- and iododeoxyuridine produce near-saturation labeling of adult proliferative populations in the dentate gyrus.
Burns KA; Kuan CY
Eur J Neurosci; 2005 Feb; 21(3):803-7. PubMed ID: 15733099
[TBL] [Abstract][Full Text] [Related]
51. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.
Fan R; Kumaravel TS; Jalali F; Marrano P; Squire JA; Bristow RG
Cancer Res; 2004 Dec; 64(23):8526-33. PubMed ID: 15574758
[TBL] [Abstract][Full Text] [Related]
52. Stem cell (CFUs) proliferation inhibitor in blood of mice injected with hydroxyurea.
Necas E
Cell Tissue Kinet; 1982 May; 15(3):263-8. PubMed ID: 7083297
[TBL] [Abstract][Full Text] [Related]
53. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of adriamycin induced DNA damage and repair in human and animal cells.
Chłopkiewicz B
Acta Pol Pharm; 2002; 59(2):115-20. PubMed ID: 12365602
[TBL] [Abstract][Full Text] [Related]
55. Gene expression profile in bone marrow and hematopoietic stem cells in mice exposed to inhaled benzene.
Faiola B; Fuller ES; Wong VA; Recio L
Mutat Res; 2004 May; 549(1-2):195-212. PubMed ID: 15120971
[TBL] [Abstract][Full Text] [Related]
56. In vitro hematopoietic differentiation of human embryonic stem cells induced by co-culture with human bone marrow stromal cells and low dose cytokines.
Wang J; Zhao HP; Lin G; Xie CQ; Nie DS; Wang QR; Lu GX
Cell Biol Int; 2005 Aug; 29(8):654-61. PubMed ID: 15950498
[TBL] [Abstract][Full Text] [Related]
57. Cell cycle phase dependent role of DNA polymerase beta in DNA repair and survival after ionizing radiation.
Vermeulen C; Verwijs-Janssen M; Begg AC; Vens C
Radiother Oncol; 2008 Mar; 86(3):391-8. PubMed ID: 18237797
[TBL] [Abstract][Full Text] [Related]
58. Effects of motexafin gadolinium on DNA damage and X-ray-induced DNA damage repair, as assessed by the Comet assay.
Donnelly ET; Liu Y; Paul TK; Rockwell S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1176-86. PubMed ID: 15990023
[TBL] [Abstract][Full Text] [Related]
59. Differences in DNA damage and repair produced by systemic, hepatocarcinogenic and sarcomagenic dibenzocarbazole derivatives in a model of rat liver progenitor cells.
Valovicová Z; Marvanová S; Mészárosová M; Srancíková A; Trilecová L; Milcová A; Líbalová H; Vondrácek J; Machala M; Topinka J; Gábelová A
Mutat Res; 2009 Jun; 665(1-2):51-60. PubMed ID: 19427511
[TBL] [Abstract][Full Text] [Related]
60. Enhanced oligonucleotide-directed gene targeting in mammalian cells following treatment with DNA damaging agents.
Ferrara L; Parekh-Olmedo H; Kmiec EB
Exp Cell Res; 2004 Oct; 300(1):170-9. PubMed ID: 15383324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
